a b s t r a c t
The involvement of muscarinic cholinoceptors within the ventromedial hypothalamic nuclei (VMH) on the exercise-induced increase in oxygen consumption (VO 2 ) was investigated. Rats were fitted with bilateral cannulae into the VMH for local delivery of drugs. On the day of the experiments, the animals were submitted to running exercise (20 m/min; 5% grade) until the point of fatigue. VO 2 was continuously measured after bilateral injections of either 0.2 L of 5 × 10 −9 mol methylatropine or 0.15 M NaCl solution into the VMH. Control experiments were conducted in freely moving rats on the treadmill. Muscarinic blockade within the VMH reduced time to fatigue by 32% and enhanced the increase in VO 2 from the 8th until the 17th min of exercise when compared to the control trial. In fact, time to fatigue was negatively correlated to the rate of increase in VO 2 (r 2 = 0.747; P < 0.001). However, bilateral injections of methylatropine in freely moving rats did not change VO 2 in comparison to saline injections. In conclusion, muscarinic cholinoceptors within the VMH are activated during exercise to modulate the increase in metabolic rate. Furthermore, blocking muscarinic transmission leads to a faster increase in VO 2 that is associated with the early interruption of exercise.
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Physical exercise is characterized by augmented energy expenditure that is a consequence of the increased metabolic rate in the contracting muscles. To match these higher metabolic demands, coordinated physiological responses are triggered to supply oxygen and energetic substrates to the active muscles and also to remove the products of metabolism. The mobilization of energy stores mediated by the neuroendocrine system, the redistribution of blood flow among the vascular beds and the increased arterial perfusion pressure are the marks of an exercising mammal [4, 16, 17] . Aside from the above-mentioned demands on cardiovascular and neuroendocrine systems, this higher metabolic rate also changes body temperature homeostasis during prolonged exercise [2, 5] . The efficiency of working muscles in converting chemical into mechanical energy is around 20-25% [1] and therefore, 75-80% of energy produced during ATP breakdown is released as heat from the muscles to the organism. Additionally, activation of heat loss mechanisms has a longer time-constant than heat production, and this delay leads to an increase in core body temperature * Corresponding author. Tel.: +55 31 3409 2936; fax: +55 31 3409 2924.
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(T core ) during exercise performed in cool or hot environments [7, 8, 26] .
There is experimental evidence showing the involvement of central cholinergic transmission in the control of metabolic, thermoregulatory and cardiovascular responses during exercise [10, 14, 24, 25] . Regarding the effects in the control of mechanical efficiency and, consequently, in heat production, the role of brain cholinoceptors remains unclear. Stimulating the cholinergic central system with intracerebroventricular (icv) physostigmine raises oxygen consumption (VO 2 ) in freely moving rats, however it does not change the increase evoked by exercise [15] .
The ventromedial hypothalamic nucleus (VMH) is one of the major brain areas controlling energy expenditure; the VMH modulates the sympathoadrenal activity and the mobilization of glucose and free fatty acids during exercise [18, 19, 23] . The existence of muscarinic receptors that bind acetylcholine within the VMH was shown by an autoradiographic study [6] and functional studies support the participation of acetylcholine-receptive neurons in this hypothalamic area in liver glucose mobilization, a marker of sympathetic stimulation [22] . Furthermore, bilateral injections of methylatropine into the VMH enhanced the exercise-induced increase in T core as a consequence of the delayed activation of tail heat loss mechanisms [25] . Whether the higher T core induced by 0304 muscarinic blockade was also brought about by enhanced heat production remains to be elucidated.
Therefore, the present study aimed at investigating the role of muscarinic cholinoceptors within the VMH on the exercise-induced increase in VO 2 . We also investigated whether the decreased exercise time to fatigue, induced by blocking VMH cholinoceptors, was related to changes in mechanical efficiency and in the magnitude of VO 2 increase during treadmill running.
Adult male Wistar rats were used in all experiments. Initially, the animals were housed four per standard polyethylene cage. After implantation of the brain cannulae (body weight 266 ± 16 g; mean ± SD), rats were housed individually. The cages were kept in a room with controlled light (05:00-19:00 h) and temperature (22.6 ± 0.8 • C; mean ± SD) conditions; standard rat chow and tap water were provided ad libitum. All proposed experimental procedures were approved by the Ethics Committee of the Federal University of Minas Gerais for the Care and Use of Laboratory Animals (protocol 017/05).
Under anesthesia that was achieved with ketamine and xylazine (116 and 6 mg/kg body wt i.p.), the animals were fixed to a stereotaxic apparatus. Using a previously described technique [24, 25] sterile stainless steel cannulae (20.0 mm in length, 0.3 mm OD, 0.1 mm ID) were implanted bilaterally so that the tip of each cannula was aimed at the dorsal aspect of the VMH. The following stereotaxic coordinates were used: AP, 2.5 mm posterior to bregma; ML, 0.6 mm from the midline; DV, 9.0 mm below the dura mater [13] .
After the surgery, the rats received an intramuscular prophylactic dose of antibiotics (pentabiotic 24,000 IU/kg body wt) and a subcutaneous injection of analgesic medication (fluxinin meglumine, 1.1 mg/kg body wt). All animals were allowed to recover for at least one week before being submitted to the familiarization protocol.
The rats were gradually encouraged to exercise on a treadmill for small animals (Modular Treadmill, Columbus Instruments, OH, USA) by light electrical stimulation (0.5 mA; 0.5 mV). Each familiarization session consisted of gradual increases in the treadmill velocity until each rat achieved a speed of 18 m/min that was then kept constant for 5 min. This protocol was reproduced across five consecutive days prior to the experiments [10, 25] .
All experimental trials were performed on a motor-driven treadmill at a room temperature of 23 ± 1 • C. To characterize the animals used in the present study, the maximal velocity and the maximal aerobic capacity (VO 2max ) of the rats were measured after the familiarization period. The animals were allowed to rest on the treadmill for at least 1 h before the test. The exercise protocol consisted of graded exertion on the treadmill, which was kept at a constant inclination of 5%. Initial velocity was set at 10 m/min and then the treadmill speed was increased by 1 m/min every 2 min until the point of fatigue. The latter was defined as the point at which the animals were no longer able to keep pace with the treadmill for at least 10 s [24, 25] . VO 2max of the rats was 65.2 ± 3.1 ml/kg/min, achieved at a speed of 24 ± 1 m/min.
The additional experiments involving physical exercise were performed at a constant velocity of 20 m/min with a 5% inclination, which corresponded to 83 ± 3% of the maximal velocity achieved during the graded test. Each rat was randomly assigned to two additional trials; receiving bilateral injections of either 0.2 L of 0.15 M NaCl solution (Sal) or 5 × 10 −9 mol methylatropine (Matr; Sigma Chemical, St. Louis, MO, USA), a competitive antagonist of muscarinic receptors. Dose selection was based on previous experiments that showed that intraventromedial injections of 5 × 10 −9 mol (2.5 × 10 −2 M) of methylatropine solution reduced time to fatigue by 31-37% [24, 25] . After a resting period of at least 60 min, a 1 L Hamilton syringe connected to polyethylene tubing was used to inject the drugs. The injection procedure lasted 1 min in each nucleus and, 10 min after the injections, the animals were submitted to exercise until the point of fatigue.
Both experimental conditions were performed at the same time of day with an interval of at least two days between exercise trials. The order of the trials was randomized, and care was taken to ensure that the experimenter who determined the point of fatigue remained blind to the solution injected during each experimental trial throughout the investigation.
Control experiments were conducted in resting rats. The animals were submitted to similar experimental procedures, unless they were allowed to move freely on the treadmill for 60 min after the injections. Each rat was submitted to two experimental trials -Sal or Matr -with an interval of at least two days.
Oxygen consumption (VO 2 ) was measured by an open-flow indirect calorimeter (Columbus Instruments) calibrated before each use with a certified mixture of gases (20.5% O 2 and 0.5% CO 2 ). VO 2 (ml/kg/min) was continuously recorded on-line, every minute at rest and during exercise until the point of fatigue, using a computerized system (Oxymax Apparatus, Columbus Instruments).
Time to fatigue and workload were considered indexes of exercise performance. Both W and VO 2 were converted to kcal and then mechanical efficiency was compared between the trials at two different time points: at the point of fatigue and at the 17th min of exercise (when the methylatropine-treated rats stopped running). Mechanical efficiency was calculated as (W/VO 2 ) × 100 and the results were presented as percentages.
At the end of the experiments, rats were deeply anesthetized with pentobarbital sodium (75 mg/kg body wt i.p.) and perfused with 0.9% NaCl followed by 10% formalin solution. After perfusion, the brains were removed, post-fixed by immersion in formalin solution for 24 h and ultimately transferred to a solution of sucrose 30% kept at 4 • C for at least 2 days. The brains were then frozen at −13 • C and cut into 50 m slices using a cryostat microtome (Microm, Riverstone, NSW, USA). Sections were mounted on slides and then stained with cresyl violet for histological verification of the injection sites in the hypothalamus. The position of the cannulae in the brain was confirmed by comparing it to the description in Paxinos and Watson's atlas [13] . A representative photomicrographic image of a coronal slice of the brain showing the cannulae placed bilaterally in the VMH is presented in Fig. 1 .
Data are expressed as means ± SEM, unless otherwise stated in parentheses. Time to fatigue, workload and mechanical efficiency were compared between treatments using paired Student's t-test. Differences in VO 2 were compared across treatments and time points using a multiple factor analysis of variance followed by the least significant difference test. The correlation between the rate of increase in VO 2 or mechanical efficiency and the time to fatigue was assessed using Pearson's correlation coefficient. The significance level was set at P < 0.05.
The rats ran for an average of 25.1 min at 20 m/min and 5% grade after the control injections of saline. Time to fatigue during the control exercise trial when rats ran at a constant intensity was positively correlated to time to fatigue during graded-intensity exercise (r 2 = 0.595, P = 0.015).
As expected, cholinergic blockade of the VMH reduced time to fatigue by 32% (17.0 ± 2.1 min Matr vs. 25.1 ± 4.2 min Sal; P = 0.019). Workload, another index of exercise performance, was also decreased by intraventromedial injections of methylatropine (109 ± 14 kgm Matr vs. 156 ± 25 kgm Sal; P = 0.018).
Intraventromedial saline injections induced a small and transient increase in VO 2 when the rats were allowed to move freely on the treadmill (Fig. 2A) . The increase in VO 2 induced by handling and injection procedure reached a peak of 17.4 ± 1.4 ml/kg/min 15 min after the injections and then gradually decreased towards resting levels. This transient increase was also observed after bilateral injections of methylatropine; however, muscarinic blockade of the VMH did not change VO 2 in comparison to the control trial.
Physical exercise induced a sharp increase in metabolic rate in both experimental trials (Fig. 2B) . In the control trial, VO 2 increased progressively until the 19th min of exercise, when it reached a plateau around 61 ml/kg/min. The VO 2 values at the point of fatigue were 4-fold higher when compared to resting values obtained just before saline injections. On the other hand, the increase in metabolic rate was anticipated after muscarinic blockade of the VMH and stabilized at the 15th min of exercise. VO 2 values during the Matr trial were higher from the 8th until the 17th min of exercise in comparison to the Sal trial. Therefore, at the 17th min of exercise (i.e., the point of fatigue for Matr-treated rats), mechanical efficiency decreased after the muscarinic blockade (14.4 ± 0.4% Matr vs. 15.9 ± 0.6% Sal; P < 0.01).
Despite these changes in metabolism during the initial minutes of exercise, no differences were observed between trials with regard to VO 2 or mechanical efficiency at the point of fatigue (VO 2 : 64.6 ± 1.8 ml/kg/min Matr vs. 63.3 ± 1.1 ml/kg/min Sal; mechanical efficiency: 14.4 ± 0.4% Matr vs. 14.7 ± 0.3% Sal). Moreover, when the metabolic rate was adjusted as a function of time to fatigue percentage, the faster increase in VO 2 during exercise caused by muscarinic blockade was no longer observed (Fig. 3A) . After intraventromedial methylatropine, VO 2 was reduced from 20% to 40% of time to fatigue as compared to values observed after saline injections.
To assess whether the decreased performance of methylatropine-treated rats was associated with the changes in metabolic rate, we correlated the increase in VO 2 by distance traveled and the time to fatigue (Fig. 3B) . In fact, these parameters presented a significant inverse correlation (r 2 = 0.747, P < 0.001). In addition, a strong positive correlation was observed between the mechanical efficiency at the 17th min and the time to fatigue (r 2 = 0.778, P < 0.001; Fig. 3C ). The main finding of the present study was that the blockade of VMH muscarinic cholinoceptors induced a faster increase in VO 2 and decreased mechanical efficiency during physical exercise. Interestingly, the faster rise in metabolic rate was correlated with reduced running performance of the methylatropine-treated animals. However, despite these early effects on metabolism, no differences were observed between trials in VO 2 or mechanical efficiency at the point of fatigue.
Until the present study, no experiments had utilized the central injection of cholinergic antagonists, a step necessary to determine if brain acetylcholine is released to adjust metabolic rate during exercise. Although central cholinergic stimulation with icv physostigmine increases VO 2 in resting conditions, no effects were observed while rats were running on a treadmill [15] . It is possible to assume that central cholinergic stimulation increases spontaneous physical activity and then VO 2 of freely moving rats; however, exercise may overcome these metabolic effects induced by icv physostigmine. Therefore, blocking the muscarinic receptors within the VMH allowed us to demonstrate that endogenous acetylcholine released from nerve terminals, at least, in discrete hypothalamic nuclei, is important to adjust metabolic rate during exercise.
The impaired performance during prolonged exercise after central muscarinic blockade is a well described phenomenon [10, 11] that involves receptors located in the VMH [24, 25] . There is evidence that this hypothalamic area modulates metabolic, cardiovascular, hormonal and thermoregulatory responses to exercise [18, 19, [23] [24] [25] . On the other hand, VMH neurons did not express c-fos during a high-intensity running exercise that increased plasmatic concentrations of lactate and adrenaline and also induced expression of the immediate early gene in many other hypothalamic [21] and medullary nuclei [12] . However, the latter result cannot be ruled out as a false negative because the use of c-fos as a marker of brain activity has some limitations; for example, not all neurons express c-fos when stimulated [3] .
After the bilateral injections of methylatropine, the rats presented an enhanced increase of VO 2 during the initial minutes of exercise. In our previous experiments, methylatropine injections into the VMH delayed the activation of tail heat loss mechanisms, which led to a faster rate of heat storage [25] . Therefore, the present results show that, aside from delaying the activation of cutaneous heat loss, blockade of muscarinic cholinoceptors within the VMH also enhances exercise-induced increases in T core by increasing heat production. It is important to emphasize that the changes in heat balance during the initial minutes of exercise, although important for determining physical performance, were no longer observed when the treatments were compared at the point of fatigue. The differences between trials in VO 2 were minimized when the parameter was plotted as a function of percentage of time to fatigue, following the same patterns previously observed for exercise-induced increases in T core [25] and mean arterial pressure [24] .
As mentioned earlier, the faster increase in VO 2 values observed for methylatropine-treated rats was associated with inferior physical performance. This result is in agreement with previous reports in which central pharmacological manipulations that enhanced the exercise-induced increase in VO 2 were associated with a decreased running time to fatigue [7, 9, 20 ]. An inadequate running technique leading to decreased mechanical efficiency would explain why VO 2 was higher after bilateral muscarinic blockade within the VMH. In fact, it was observed that, when the methylatropine-treated rats stopped running (at the 17th min), their mechanical efficiency was reduced in comparison to control rats and this inefficiency was associated with the early interruption of exercise.
The control experiments with resting rats were important because they showed that the transient rise in metabolic rate caused by the injection procedure ( VO 2 = 2.9 ± 1.5 ml/kg/min, 15 min, Sal trial), which involved handling and restraint of the animal, is quite small when compared to the effects evoked by physical exercise. The maximal response after the injections of saline was about 7% of the exercise-induced increase in VO 2 (40.9 ± 1.8 ml/kg/min, at the point of fatigue, Sal trial). This observation indicates that the possible stress associated with the injection procedure interfered minimally with the methylatropine-induced changes in metabolic rate during exercise.
In conclusion, bilateral blockade of VMH muscarinic cholinoceptors decreases mechanical efficiency, enhancing the increase in oxygen consumption during the early minutes of exercise. These responses are associated with a reduction in physical performance. The present data provide the first evidence showing that muscarinic cholinoceptors within the VMH are involved in the neural circuitry that adjusts the metabolic rate during physical exercise.
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